Skip to main content

Anesthesia for Pituitary Lesions

  • Chapter
  • First Online:
Textbook of Neuroanesthesia and Neurocritical Care
  • 1261 Accesses

Abstract

The goal of this chapter is to provide the anesthesiologists with detailed information about the anesthetic management in patients undergoing surgery for the treatment of the pituitary diseases. The peculiar features of the underlying endocrine disturbances are illustrated. Knowledge of anatomy and pathophysiology of the pituitary gland is paramount to understand the potential complications: pituitary gland function and signs and symptoms of pituitary tumors related both to hormonal hypersecretion and hyposecretion syndromes are illustrated. Pituitary surgery has evolved over the last two decades from an open transcranial surgery to the minimally invasive endoscopic endonasal approach: surgical techniques of pituitary tumors and their advantages and disadvantages are briefly summarized. In those patients complaining of a pituitary adenoma, preoperative endocrinological assessment and tailored management strategies are required to reduce the morbidity related to the surgical pituitary procedure itself, above all, upon anesthetic issues. Therefore, multidisciplinary team case discussion is of utmost importance to rule out the optimal therapeutic option before surgery. Different anesthetic modalities and drugs can be used adequately in the intraoperative period avoiding complications and thus providing an uneventful recovery. The main goals of the anesthetic treatment include the hemodynamic stability, airway management, quick and smooth awakening at the end of surgical procedure, and prevention of intra- and postoperative complications. Anesthetic management with particular attention to that of patients suffering from acromegaly and Cushing disease is outlined. Finally, the main postoperative issues are illustrated: usually, after undergoing an endoscopic endonasal procedure, patients don’t require intensive care unit admission, unless in extraordinary conditions and/or depending on preexisting comorbidities. In these patients, the postoperative issues are mainly related to airways management, pain management, neurological and endocrine status, and fluid balance control. Endocrine disorders include hypopituitarism, diabetes insipidus, and inappropriate secretion of antidiuretic hormone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenne C, editors. WHO classification of tumours of the central nervous system. 4th ed. Lyon: IARC; 2016.

    Google Scholar 

  2. Del Basso De Caro M, Solari D, Pagliuca F, et al. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev. 2017;40(1):105–14.

    Article  PubMed  Google Scholar 

  3. Carroll PV, Jenkins PJ. Acromegaly. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., eds. Endotext. 2016. https://www.ncbi.nlm.nih.gov/books/NBK279097/. Accessed 11 June 2018.

  4. Asa SL, Kucharczyk W, Ezzat S. Pituitary acromegaly: not one disease. Endocr Relat Cancer. 2017;24(3):C1–4.

    Article  PubMed  Google Scholar 

  5. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367(9522):1605–17.

    Article  CAS  PubMed  Google Scholar 

  6. Wang EL, Qian ZR, Yamada S, et al. Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol. 2009;20(4):209–20.

    Article  CAS  PubMed  Google Scholar 

  7. Klibanski A. Clinical practice. Prolactinomas. N Engl J Med. 2010;362(13):1219–26.

    Article  CAS  PubMed  Google Scholar 

  8. Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017;8(3):33–48.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Laws ER Jr, Onofrio BM, Pearson BW, McDonald TJ, Dirrenberger RAR. Successful management of bilateral carotid-cavernous fistulae with a transsphenoidal approach. Neurosurgery. 1979;4(2):162–7.

    Article  PubMed  Google Scholar 

  10. Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M. Endoscopic pituitary tumor surgery. Laryngoscope. 1992;102(2):198–202.

    Article  CAS  PubMed  Google Scholar 

  11. Jho HD, Carrau R. Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note. Acta Neurochir. 1996;138(12):1416–25.

    Article  CAS  PubMed  Google Scholar 

  12. Cappabianca P, Alfieri A, de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Minim Invasive Neurosurg. 1998;41(2):66–73.

    Article  CAS  PubMed  Google Scholar 

  13. Kuan EC, Yoo F, Kim W, Badran KW, Heineman TE, Sepahdari AR, Bergsneider M, Wang MB. Anatomic variations in pituitary endocrinopathies: implications for the surgical corridor. J Neurol Surg B Skull Base. 2017;78(2):105–11.

    Article  PubMed  Google Scholar 

  14. Cappabianca P, Alfieri A, Coloa A. Endoscopic endonasal transsphenoidal surgery in recurrent and residual pituitary adenomas: technical note. Minim Invasive Neurosurg. 2000;43(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  15. de Divitiis E. Endoscopic transsphenoidal surgery: stone-in-the-pond effect. Neurosurgery. 2006;59(3):512–20.

    Article  PubMed  Google Scholar 

  16. Cappabianca P, Cavallo LM, de Divitiis E. Endoscopic endonasal transsphenoidal surgery. Neurosurgery. 2004;55(4):933–40.. discussion 940–1.

    Article  PubMed  Google Scholar 

  17. Cavallo LM, Dal Fabbro M, Jalalod’din H, Messina A, Esposito I, Esposito F, et al. Endoscopic endonasal transsphenoidal surgery. Before scrubbing in: tips and tricks. Surg Neurol. 2007;67:342–7.

    Article  PubMed  Google Scholar 

  18. Louis RG, Pouratian AG, Jane JA Jr. Endoscopic approaches for pituitary tumors. In: Kassam AB, Gardner PA, editors. Endoscopic approaches for skull base. Basel, Switzerland: S. Karger AG; 2012. p. 60–75.

    Chapter  Google Scholar 

  19. Leach P, Abou-Zeid AH, Kearney T, Davis J, Trainer PJ, Gnanalingham KK. Endoscopic transsphenoidal pituitary surgery: evidence of an operative learning curve. Neurosurgery. 2010;67(5):1205–12.

    Article  PubMed  Google Scholar 

  20. Ali Z, Prabhakar H, Bithal PK, Dash HH. Bispectral index-guided administration of anesthesia for transsphenoidal resection of pituitary tumors: a comparison of 3 anesthetic techniques. J Neurosurg Anesthesiol. 2009;21(1):10–5.

    Article  PubMed  Google Scholar 

  21. Cafiero T, Mastronardi P, Gargiulo G, Cappabianca P, Cavallo LM. Intraoperative analgesia with remifentanil for the endonasal endoscopic approach to pituitary lesions. Anesthesiology. 2002;96:A70.

    Article  Google Scholar 

  22. Chelliah YR, Manninen PH. Hazards of epinephrine in transsphenoidal pituitary surgery. J Neurosurg Anesthesiol. 2002;14(1):43–6.

    Article  PubMed  Google Scholar 

  23. Pasternak JJ, Atkinson JL, Kasperbauer JL, Lanier WL. Hemodynamic responses to epinephrine-containing local anesthetic injection and to emergence from general anesthesia in transsphenoidal hypophysectomy patients. J Neurosurg Anesthesiol. 2004;16(3):189–95.

    Article  PubMed  Google Scholar 

  24. Cafiero T, Cavallo LM, Frangiosa A, Burrelli R, Gargiulo G, Cappabianca P, de Divitiis E. Clinical comparison of remifentanil-sevoflurane vs. remifentanil-propofol for endoscopic endonasal transsphenoidal surgery. Eur J Anaesthesiol. 2007;24(5):441–6.

    Article  CAS  PubMed  Google Scholar 

  25. Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017;8:CD012763.

    PubMed  Google Scholar 

  26. Ünal DY, Baran İ, Mutlu M, Ural G, Akkaya T, Özlü O. Comparison of sugammadex versus neostigmine costs and respiratory complications in patients with obstructive sleep apnoea. Turk J Anaesthesiol Reanim. 2015;43(6):387–95.

    PubMed  PubMed Central  Google Scholar 

  27. Laws ER. Surgery for acromegaly: evolution of the techniques and outcomes. Rev Endocr Metab Disord. 2008;9(1):67–70.

    Article  PubMed  Google Scholar 

  28. Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications. Int J Endocrinol. 2012;2012:386401.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Friedel ME, Johnston DR, Singhal S, Al Khalili K, Farrell CJ, Evans JJ, Nyquist GG, Rosen MR. Airway management and perioperative concerns in acromegaly patients undergoing endoscopic transsphenoidal surgery for pituitary tumors. Otolaryngol Head Neck Surg. 2013;149(6):840–4.

    Article  PubMed  Google Scholar 

  30. Nemergut EC, Zuo Z. Airway management in patients with pituitary disease: a review of 746 patients. J Neurosurg Anesthesiol. 2006;18(1):73–7.

    Article  PubMed  Google Scholar 

  31. Zhang Y, Guo X, Pei L, Zhang Z, Tan G, Xing B. High levels of IGF-1 predict difficult intubation of patients with acromegaly. Endocrine. 2017;57(2):326–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Bindra A, Prabhakar H, Bithal PK, Singh GP, Chowdhury T. Predicting difficult laryngoscopy in acromegalic patients undergoing surgery for excision of pituitary tumors: a comparison of extended Mallampati score with modified Mallampati classification. J Anaesthesiol Clin Pharmacol. 2013;29(2):187–90.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Law-Koune JD, Liu N, Szekely B, Fischler M. Using the intubating laryngeal mask airway for ventilation and endotracheal intubation in anesthetized and unparalyzed acromegalic patients. J Neurosurg Anesthesiol. 2004;16(1):11–3.

    Article  PubMed  Google Scholar 

  34. Paolini JB, Donati F, Drolet P. Review article: video-laryngoscopy: another tool for difficult intubation or a new paradigm in airway management? Can J Anaesth. 2013;60(2):184–91.

    Article  PubMed  Google Scholar 

  35. Agro FE, Vennari M. The videolaryngoscopes are now the first choice to see around the corner. Minerva Anestesiol. 2016;82(12):1247–9.

    PubMed  Google Scholar 

  36. Cafiero T, Esposito F, Fraioli G, Gargiulo G, Frangiosa A, Cavallo LM, Mennella N, Cappabianca P. Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. Eur J Anaesthesiol. 2008;25(8):670–4.

    Article  CAS  PubMed  Google Scholar 

  37. Clayton RN. Cardiovascular function in acromegaly. Endocr Rev. 2003;24(3):272–7.

    Article  CAS  PubMed  Google Scholar 

  38. Srinivasan A, Bahl A, Bhagat H, Dutta P, Rai A, Devgun JS, Kaur R, Mukherjee KK. Impact of transsphenoidal surgery on asymptomatic cardiomyopathy in patients with acromegaly. A single-blinded study. Neurol India. 2017;65(6):1312–6.

    Article  PubMed  Google Scholar 

  39. Chung SY, Sylvester MJ, Patel VR, Zaki M, Baredes S, Liu JK, Eloy JA. Impact of obstructive sleep apnea in transsphenoidal pituitary surgery: an analysis of inpatient data. Laryngoscope. 2018;128(5):1027–32.

    Article  PubMed  Google Scholar 

  40. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317(5):516–24.

    Article  PubMed  Google Scholar 

  41. Debono M, Newell-Price JD. Cushing’s syndrome: where and how to find it. Front Horm Res. 2016;46:15–27.

    Article  PubMed  Google Scholar 

  42. Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, Waguespack SG, Elsayes KM. Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol. 2017;209(1):19–32.

    Article  PubMed  Google Scholar 

  43. Pekic S, Popovic V. Diagnosis of endocrine disease: expanding the cause of hypopituitarism. Eur J Endocrinol. 2017;176(6):R269–82.

    Article  CAS  PubMed  Google Scholar 

  44. Johnston PC, Kennedy L, Hamrahian AH, Sandouk Z, Bena J, Hatipoglu B, Weil RJ. Surgical outcomes in patients with Cushing’s disease: the Cleveland clinic experience. Pituitary. 2017;20(4):430–40.

    Article  PubMed  Google Scholar 

  45. Czirják S, Bezzegh A, Gál A, Rácz K. Intra- and postoperative plasma ACTH concentrations in patients with Cushing’s disease cured by transsphenoidal pituitary surgery. Acta Neurochir. 2002;144(10):971–7.. discussion 977.

    Article  PubMed  Google Scholar 

  46. Marchand L, Segrestin B, Lapoirie M, Favrel V, Dementhon J, Jouanneau E, Raverot G. Dilated cardiomyopathy revealing Cushing disease: a case report and literature review. Medicine (Baltimore). 2015;94(46):e2011.

    Article  Google Scholar 

  47. Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB. Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. J Clin Endocrinol Metab. 2013;98(3):1022–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, et al. The hypertension of Cushing’s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens. 2015;33(1):44–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Heaney AP, Hunter SJ, Sheridan B, Brew Atkinson A. Increased pressor response to noradrenaline in pituitary dependent Cushing’s syndrome. Clin Endocrinol. 1999;51(3):293–9.

    Article  CAS  Google Scholar 

  50. Tack LJ, Tatsi C, Stratakis CA, Lodish MB. Effects of glucocorticoids on bone: what we can learn from pediatric endogenous Cushing’s syndrome. Horm Metab Res. 2016;48(11):764–70.

    Article  CAS  PubMed  Google Scholar 

  51. Giugni AS, Mani S, Kannan S, Hatipoglu B. Exophthalmos: a forgotten clinical sign of Cushing’s syndrome. Case Rep Endocrinol. 2013;2013:205208.

    PubMed  PubMed Central  Google Scholar 

  52. Wang LU, Wang TY, Bai YM, Hsu JW, Huang KL, Su TP, et al. Risk of obstructive sleep apnea among patients with Cushing’s syndrome: a nationwide longitudinal study. Sleep Med. 2017;36:44–7.

    Article  PubMed  Google Scholar 

  53. Ghirardello S, Hopper N, Albanese A, Maghnie M. Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab. 2006;19(Suppl. 1):413–21.

    PubMed  Google Scholar 

  54. Finken MJ, Zwaveling-Soonawala N, Walenkamp MJ, Vulsma T, van Trotsenburg AS, Rotteveel J. Frequent occurrence of the triphasic response (diabetes insipidus/hyponatremia/diabetes insipidus) after surgery for craniopharyngioma in childhood. Horm Res Paediatr. 2011;76(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  55. Hussain NS, Piper M, Ludlam WG, Ludlam WH, Fuller CJ, Mayberg MR. Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors. J Neurosurg. 2013;119(6):1453–60.

    Article  PubMed  Google Scholar 

  56. Adrogué HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol. 2012;23(7):1140–8.

    Article  PubMed  Google Scholar 

  57. Ishiguro T, Ishihara T, Hatano Y, Abe T, Shimohata T, Nishizawa M. A case of central pontine and extrapontine myelinolysis after surgery for a pituitary tumor. Rinsho Shinkeigaku. 2017;57(1):21–5.

    Article  PubMed  Google Scholar 

  58. Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis. 2010;55(4):742–8.

    Article  PubMed  Google Scholar 

  59. Gralla RJ, Ahmad F, Blais JD, Chiodo J 3rd, Zhou W, Glaser LA, Czerwiec FS. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials. Cancer Med. 2017;6(4):723–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

The author would like to thank Prof Paolo Cappabianca, Prof Luigi Maria Cavallo, and Dr Domenico Solari at the Division of Neurosurgery of UniversitĂ  degli Studi di Napoli Federico II, for having shared their experience and work all along the case series. Further, they have been a precious asset in the English language assistance and iconographic section.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cafiero, T. (2019). Anesthesia for Pituitary Lesions. In: Prabhakar, H., Ali, Z. (eds) Textbook of Neuroanesthesia and Neurocritical Care. Springer, Singapore. https://doi.org/10.1007/978-981-13-3387-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3387-3_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3386-6

  • Online ISBN: 978-981-13-3387-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics